GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 27 | 61 | 368 | 342 | 26 |
| Cost of Goods | 27 | 57 | 226 | 94 | 48 |
| Gross Profit | 27 | 4 | 142 | 248 | -22 |
| Operating Expenses | 8,981 | 2,457 | 1,161 | 3,856 | 3,954 |
| Operating Income | -8,927 | -2,396 | -793 | -3,514 | -3,928 |
| Interest Expense | 17,039 | 5,146 | 1,196 | 1,653 | 556 |
| Other Income | 4,505 | -15,947 | 1,488 | -4 | 784 |
| Pre-tax Income | -21,461 | -23,489 | -501 | -5,171 | -3,700 |
| Net Income Continuous | -21,461 | -23,489 | -501 | -5,171 | -3,700 |
| Net Income | $-21,431 | $-23,489 | $-501 | $-5,171 | $-3,700 |
| EPS Basic Total Ops | -4,576.00 | -5,153.11 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -4,576.39 | -5,150.79 | 0.00 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -4,576.00 | -5,153.11 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -4,576.39 | -5,150.79 | 0.00 | -0.01 | -0.02 |
| EBITDA(a) | $-6,458 | $385 | $-102 | $-3,471 | $-3,621 |